Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07543159 · ClinicalTrials.gov registry record
Clinical Biospecimen Collection
A clinical trial, sponsored by North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists.
- Recruiting
- Registry status
- 900,000
- Enrollment target
NCT07543159: Recruiting study, sponsored by North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists.
NCT07543159 is a clinical trial that is actively recruiting participants, run by North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists. The registered enrollment target is 900,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07543159 is actively recruiting participants, sponsored by North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists.
- RECRUITING
- Registry status
- 900,000 participants
- Enrollment target
Study Summary
New York Cancer and Blood Specialists(NYCBS) is dedicated to provide world-class, patient-centered, affordable care to patients with cancer and blood disorders in their own communities, close to family and friends. Our vision is a world free of cancer and blood disorders by contributing to the search for cures by offering cutting-edge clinical trials and personalized, state-of-the-art treatments that save and prolong lives. In support of these objectives NYCBS has created a centralized oncology biorepository in tandem with a longitudinal study to support translational research. This study establishes a biological sample bank and associated data reservoir from thousands of cancer patients, high risk populations, and survivors. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. Researchers will then use these samples and information to better understand how cancer affects the body over time in order to formulate new treatments. The information and samples provided will allow the testing of new therapies and aid in the development of new medical treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900,000 participants |
| Start Date | 2025-12-23 |
| Est. Completion | 2035-10-06 |
Sponsor
North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists1 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07543159
The ClinicalTrials.gov registry entry for NCT07543159 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 900,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07543159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07543159 about?
NCT07543159 is a clinical study titled "Clinical Biospecimen Collection". New York Cancer and Blood Specialists(NYCBS) is dedicated to provide world-class, patient-centered, affordable care to patients with cancer and blood disorders in their own communities, close to family and friends. Our vision is a world free of cancer and blood disorders by contributing to the searc...
What is the current status of trial NCT07543159?
This trial is currently recruiting. The enrollment target is 900,000 participants. The study started on 2025-12-23. Estimated completion is 2035-10-06.
Who is sponsoring clinical trial NCT07543159?
This trial is sponsored by North Shore Hematology Oncology Associates P.C dba New York Cancer and Blood Specialists, which has 1 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.